Results 131 to 140 of about 2,302,279 (319)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

[SDC] [r]esponse form for the consultation on the review of the 'Strategy for sustainable construction'

open access: yes, 2012
Our input into the 'Strategy for sustainable construction' highlights that this an important opportunity for Government to show inspirational leadership through its role as a the UK's largest construction client.Publisher ...
Sustainable Development Commission
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Comprehensive area assessment consultation

open access: yes, 2012
The proposals for the new comprehensive area assessment are a very positive step forward for sustainable development compared to previous local performance assessment frameworks, but will need further strengthening if they are to help support the ...
Sustainable Development Commission
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Sustainability and UK food policy 2000-2011

open access: yes, 2012
A report on food, farming, sustainable consumption and production.Publisher ...
Sustainable Development Commission
core  

Life cycle assessment of deep eutectic solvent employment for sustainable nanocellulose production from biomass: a systematic review

open access: yesGreen Chemistry Letters and Reviews
Nanocellulose has been the research focus in recent years due to its unique properties, diverse potential applications, and the availability of abundant biomass sources.
Angky Wahyu Putranto   +5 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Sustainable communities : qualitative householder research findings from South Cambridgeshire and Barking and Dagenham

open access: yes, 2012
This report is part of the evidence base for 'In-depth review of sustainable communities policy'.This qualitative householder research was carried out to complement the Area-Based Assessments undertaken on behalf of the Sustainable Development Commission.
Sustainable Development Commission
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy